This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ryvu Therapeutics S.a.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Marcin Wojciech Les: Innovator in Heterocyclic Compounds
Introduction
Marcin Wojciech Les is a notable inventor based in Poland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the Stimulator of Interferon Genes (STING). His work focuses on innovative approaches to enhance therapeutic options for various diseases.
Latest Patents
Marcin Wojciech Les holds a patent titled "Heterocyclic Compounds As Modulators Of Stimulator Of Interferon Genes (Sting)." This invention relates to compounds of formula (I) and their derivatives, which are useful as modulators of STING. The compounds are designed for use as medicaments and are included in pharmaceutical compositions.
Career Highlights
Throughout his career, Marcin Wojciech Les has demonstrated a commitment to advancing scientific knowledge and developing new therapeutic strategies. His research has the potential to impact the treatment of diseases that involve the immune system.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Marcin Wojciech Les is an innovative inventor whose work on heterocyclic compounds represents a significant advancement in the field of medicinal chemistry. His contributions may pave the way for new treatments that harness the power of the immune system.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile